On Wednesday April 27, ASCO released 2800+ abstract titles spanning all major tumor types. On today’s podcast, we will give you a glimpse into some of the impactful abstracts that will be presented at ASCO in June. Topics will range from practice changing Phase III results from ADCs to emerging modalities like CAR-engineered allogeneic γδ T cells.